Baseline Neutrophil-to-Eosinophil Ratio Is Associated With Outcomes in Patients With Metastatic RCC Treated With ICIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
Oncologist 2022 Nov 25;[EPub Ahead of Print], TZ Zhuang, D Ravindranathan, Y Liu, DJ Martini, JT Brown, B Nazha, G Russler, LB Yantorni, S Caulfield, BC Carthon, O Kucuk, VA Master, MA BilenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.